Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life

Lupus

Volumn 25, Issue 12, 2016, Pages 1315-1327

  Macedo E A ^a   Appenzeller, S ^a   Costallat, L T L ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anxiety; Brazil; depression; gender; quality of life; systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; CORTICOSTEROID; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ALCOHOL CONSUMPTION; ANTIPHOSPHOLIPID SYNDROME; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; SHORT FORM 36; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS; UNEMPLOYMENT; ANXIETY; CASE CONTROL STUDY; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; ANXIETY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEX FACTORS;

EID: 84988710997     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316638934     Document Type: Article

References (88)

1. Zirkzee EJ, Huizinga TW, Bollen EL, et al. Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus 2014; 23: 31-38.
2. Postal M, Costallat LT, Appenzeller S,. Neuropsychiatric manifestations in systemic lupus erythematosus: Epidemiology, pathophysiology and management. CNS Drugs 2011; 25: 721-736.
3. Palagini L, Mosca M, Tani C, Gemignani A, Mauri M, Bombardieri S,. Depression and systemic lupus erythematosus: A systematic review. Lupus 2013; 22: 409-416.
4. Iverson GL, Sawyer DC, McCracken LM, Kozora E,. Assessing depression in systemic lupus erythematosus: Determining reliable change. Lupus 2001; 10: 266-271.
5. Bachen EA, Chesney MA, Criswell LA,. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthr Rheum 2009; 61: 822-829.
6. Uguz F, Kucuk A, Cicek E, Kayhan F, Tunc R,. Mood, anxiety and personality disorders in patients with systemic lupus erythematosus. Comprehens Psychiatry 2013; 54: 341-345.
7. Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes: Relationship with antiphospholipid antibodies. Neurology 2003; 61: 108-110.
8. Nery FG, Borba EF, Viana VS, et al. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Progr Neuropsychopharmacol Biolog Psychiatry 2008; 32: 695-700.
9. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 2002; 58: 1214-1220.
10. Lim L, Ron MA, Ormerod IE, et al. Psychiatric and neurological manifestations in systemic lupus erythematosus. Q J Med 1988; 66: 27-38.
11. Wekking EM,. Psychiatric symptoms in systemic lupus erythematosus: An update. Psychosom Med 1993; 55: 219-228.
12. Shortall E, Isenberg D, Newman SP,. Factors associated with mood and mood disorders in SLE. Lupus 1995; 4: 272-279.
13. West SG, Emlen W, Wener MH, Kotzin BL,. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. Am J Med 1995; 99: 153-163.
14. Arnett FC, Reveille JD, Moutsopoulos HM, Georgescu L, Elkon KB,. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthr Rheumat 1996; 39: 1833-1839.
15. Walker SE, Smarr KL, Parker JC, Weidensaul DN, Nelson W, McMurray RW,. Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine. Lupus 2000; 9: 527-533.
16. Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA,. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2005; 32: 1459-1456.
17. Hanly JG, Su L, Farewell V, McCurdy G, Fougere L, Thompson K,. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009; 36: 1449-1459.
18. Jarpa E, Babul M, Calderon J, et al. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus 2011; 20: 58-66.
19. Karol DE, Criscione-Schreiber LG, Lin M, Clowse ME,. Depressive symptoms and associated factors in systemic lupus erythematosus. Psychosomatics 2013; 54: 443-450.
20. Postal M, Appenzeller S,. The importance of cytokines and autoantibodies in depression. Autoimmun Rev 2015; 14: 30-35.
21. Lisitsyna TA, Vel'tishchev D, Seravina OF, et al. [Prevalence of mental disorders in SLE patients: Correlations with the disease activity and comorbid chronic conditions]. Terapevticheskii Arkhiv 2009; 81: 10-16.
22. Mok CC,. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 2011; 20: 767-771.
23. Greco CM, Li T, Sattar A, et al. Association between depression and vascular disease in systemic lupus erythematosus. J Rheumatol 2012; 39: 262-268.
24. Xie LF, Chen PL, Pan HF, et al. Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience. Rheumatol Int 2012; 32: 2707-2714.
25. Zakeri Z, Shakiba M, Narouie B, Mladkova N, Ghasemi-Rad M, Khosravi A,. Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int 2012; 32: 1179-1187.
26. Moldovan I, Katsaros E, Carr FN, et al. The Patient Reported Outcomes in Lupus (PATROL) study: Role of depression in health-related quality of life in a Southern California lupus cohort. Lupus 2011; 20: 1285-1292.
27. Choi ST, Kang JI, Park IH, et al. Subscale analysis of quality of life in patients with systemic lupus erythematosus: Association with depression, fatigue, disease activity and damage. Clin Exp Rheumatol 2012; 30: 665-672.
28. Pettersson S, Lovgren M, Eriksson LE, et al. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol 2012; 41: 383-390.
29. Mak A, Tang CS, Ho RC,. Serum tumour necrosis factor-alpha is associated with poor health-related quality of life and depressive symptoms in patients with systemic lupus erythematosus. Lupus 2013; 22: 254-261.
30. Shen B, Tan W, Feng G, et al. The correlations of disease activity, socioeconomic status, quality of life and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Development Immunol 2013; 2013: 270878.
31. Shen B, Feng G, Tang W, et al. The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: A path analysis. Clin Experiment Rheumatol 2014; 32: 101-107.
32. Yilmaz-Oner S, Oner C, Dogukan FM, et al. Anxiety and depression predict quality of life in Turkish patients with systemic lupus erythematosus. Clin Experiment Rheumatol 2015; 33: 360-365.
33. Schmeding A, Schneider M,. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2013; 27: 363-375.
34. Wallace DJ, Hahn BH,. Dubois lupus erythematosus and related syndromes, 8th ed. Philadelphia: Elsevier, 2013.
35. Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR,. Kelley's textbook of rheumatology, 9th ed. Philadelphia: Elsevier, 2013.
36. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH,. Rheumatology, 6th ed. Philadelphia: Elsevier, 2015.
37. Tan TC, Fang H, Magder LS, Petri MA,. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol 2012; 39: 759-769.
38. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthrit Rheumatism 1982; 25: 1271-1277.
39. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthrit Rheumatism 1997; 40: 1725.
40. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J,. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
41. Gorenstein C, Andrade L,. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Brazil J Med Biolog Res 1996; 29: 453-457.
42. Radloff LS,. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psycholog Measurem 1977; 1: 385-401.
43. Silveira DX, Jorge MR,. Propriedades psicométricas da escala de rastreamento populacional para depressão CES-D em populações clínica e não-clínica de adolescentes e adultos jovens. Rev Psiq Clín 1998; 25: 251-261.
44. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scandinav 1983; 67: 361-370.
45. Botega NJ, Bio MR, Zomignani MA, Garcia Jr C, Pereira WAB,. Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Rev Saúde Pública 1995; 29: 355-363.
46. American College of Rheumatology (ACR). The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthr Rheum 1999; 42: 599-608.
47. Ware JE Jr, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
48. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR,. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Braz J Rheum 1999; 39: 143-150.
49. Brazilian Association of Research Companies. 2014 Economic Classification Criteria Brazil, http://www.abep.org/criterio-brasil (2014, accessed 25 December 2015).
50. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthr Rheum 1996; 39: 363-369.
51. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH,. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthr Rheum 1992; 35: 630-640.
52. Harris EN, Gharavi AE, Patel SP, Hughes GR,. Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-222.
53. Brandt JT, Triplett DA, Alving B, Scharrer I,. Criteria for the diagnosis of lupus anticoagulants: An update on behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thrombos Haemostas 1995; 74: 1185-1190.
54. Connover WJ,. Practical nonparametric statistics, 3rd ed. New York: John Wiley and Sons, 1999.
55. Fleiss JL,. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley and Sons, 1981.
56. SAS Institute Inc. Base SAS 9.4 procedures guide: statiscal procedures, December 2013.
57. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A,. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496-500.
58. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992.
59. Van Exel E, Jacobs J, Korswagen LA, et al. Depression in systemic lupus erythematosus, dependent on or independent of severity of disease. Lupus 2013; 22: 1462-1469.
60. Maneeton B, Maneeton N, Louthrenoo W,. Prevalence and predictors of depression in patients with systemic lupus erythematosus: A cross-sectional study. Neuropsychiatr Dis Treat 2013; 9: 799-804.
61. Julian LJ, Gregorich SE, Tonner C, et al. Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Arthr Care Res 2011; 63: 884-890.
62. Petri M, Naqibuddin M, Carson KA, et al. Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol 2010; 37: 2032-2038.
63. Liang MH, Rogers M, Larson M, et al. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthr Rheum 1984; 27: 13-19.
64. Lim LC, Lee TE, Boey ML,. Psychiatric manifestation of systemic lupus erythematosus in Singapore. A cross-cultural comparison. Brit J Psychiatry 1991; 159: 520-523.
65. Magner MB,. Psychiatric morbidity in outpatients with systemic lupus erythematosus. South African Med J 1991; 80: 291-293.
66. Silva MT, Galvao TF, Martins SS, Pereira MG,. Prevalence of depression morbidity among Brazilian adults: A systematic review and meta-analysis. Revista Brasileira Psiquiatria 2014; 36: 262-270.
67. Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011; 9: 90.
68. Angst J, Gamma A, Gastpar M, et al. Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatr Clin Neurosci 2002; 252: 201-209.
69. Zoma A,. Musculoskeletal involvement in systemic lupus erythematosus. Lupus 2004; 13: 851-853.
70. Murphy NG, Koolvisoot A, Schumacher R Jr, Von Feldt JM, Callegari PE,. Musculoskeletal features in systemic lupus erythematosus and their relationship with disability. J Clin Rheumatol 1998; 4: 238-245.
71. Gallop K, Nixon A, Swinburn P, Sterling KL, Naegeli AN, Silk ME,. Development of a conceptual model of health-related quality of life for systemic lupus erythematosus from the patient's perspective. Lupus 2012; 21: 934-943.
72. Barnado A, Wheless L, Meyer AK, Gilkeson GS, Kamen DL,. Quality of life in patients with systemic lupus erythematosus (SLE) compared with related controls within a unique African American population. Lupus 2012; 21: 563-569.
73. Doria A, Rinaldi S, Ermani M, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology 2004; 43: 1580-1586.
74. Sliem H, Tawfik G, Khalil KA, Ibrahim N,. Pattern of systemic lupus erythematosus in Egyptian patients: The impact of disease activity on the quality of life. Pan African Med J 2010; 6: 14.
75. Sweet JJ, Doninger NA, Zee PC, Wagner LI,. Factors influencing cognitive function, sleep and quality of life in individuals with systemic lupus erythematosus: A review of the literature. Clin Neuropsychol 2004; 18: 132-147.
76. Skare T, Da Silva Magalhaes VD, Siqueira RE,. Systemic lupus erythematosus activity and depression. Rheumatol Int 2014; 34: 445-446.
77. Morrison E, Carpentier S, Shaw E, Doucette S, Hanly JG,. Neuropsychiatric systemic lupus erythematosus: Association with global disease activity. Lupus 2014; 23: 370-377.
78. Iverson GL,. Psychopathology associated with systemic lupus erythematosus: A methodological review. Semin Arthrit Rheumat 1993; 22: 242-251.
79. Segui J, Ramos-Casals M, Garcia-Carrasco M, et al. Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: A longitudinal study of active and inactive stages of the disease. Lupus 2000; 9: 584-588.
80. Huang X, Magder LS, Petri M,. Predictors of incident depression in systemic lupus erythematosus. J Rheumatol 2014; 41: 1823-1833.
81. Utset TO, Golden M, Siberry G, Kiri N, Crum RM, Petri M,. Depressive symptoms in patients with systemic lupus erythematosus: Association with central nervous system lupus and Sjogren's syndrome. J Rheumatol 1994; 21: 2039-2045.
82. Schneebaum AB, Singleton JD, West SG, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991; 90: 54-62.
83. Nojima Y, Minota S, Yamada A, Takaku F, Aotsuka S, Yokohari R,. Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheumat Dis 1992; 51: 1053-1055.
84. Gerli R, Caponi L, Tincani A, et al. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: Prospective evaluation in a large cohort of Italian patients. Rheumatology 2002; 41: 1357-1366.
85. Andreeva E, Magnusson Hanson LL, Westerlund H, Theorell T, Brenner MH,. Depressive symptoms as a cause and effect of job loss in men and women: Evidence in the context of organisational downsizing from the Swedish Longitudinal Occupational Survey of Health. BMC Public Health 2015; 15: 1045.
86. Ruiz-Irastorza G, Danza A, Khamashta M,. Glucocorticoid use and abuse in SLE. Rheumatology 2012; 51: 1145-1153.
87. Mosca M, Tani C, Carli L, Bombardieri S,. Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol 2011; 29: S126-129.
88. Warrington TP, Bostwick JM,. Psychiatric adverse effects of corticosteroids. Mayo Clinic Proceed 2006; 81: 1361-1367.